Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vasiliki Pantazou

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
CNS Drugs|January 11, 2019
Intravenous Corticosteroids as an Adjunctive Treatment for Refractory and Super-Refractory Status Epilepticus: An Observational Cohort StudyVasiliki Pantazou, Jan Novy, Andrea O Rossetti
Presse Medicale (Paris, France : 1983)|March 7, 2015
Environmental factors in multiple sclerosisVasiliki Pantazou, Myriam Schluep, Renaud Du Pasquier
Life (Basel, Switzerland)|April 3, 2021
Interaction between Neurons and the Oligodendroglial Lineage in Multiple Sclerosis and Its Preclinical ModelsVasiliki Pantazou, Thomas Roux, Vanessa Oliveira Moreira, et al.
BMC Infectious Diseases|October 15, 2020
Vaccine-associated measles in a patient treated with natalizumab: a case reportAlix Miauton, Rainer Tan, Vasiliki Pantazou, et al.
Multiple Sclerosis and Related Disorders|April 10, 2021
Recurrence of disease activity after fingolimod discontinuation in older patients previously stable on treatmentVasiliki Pantazou, Caroline Pot, Renaud Du Pasquier, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 22, 2020
ANCA-associated life-threatening systemic vasculitis after alemtuzumab treatment for multiple sclerosisAlice Horisberger, Vasiliki Pantazou, Géraldine Cuendet, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|June 24, 2021
Discussing Challenges in Diagnosis of Tuberculous Meningitis and NeurosarcoidosisAlba Santos, Florian Desgranges, Marina Jovanovic, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 30, 2023
Ocrelizumab Impairs the Phenotype and Function of Memory CD8<sup>+</sup> T Cells: A 1-Year Longitudinal Study in Patients With Multiple SclerosisAmandine Mathias, Vasiliki Pantazou, Sylvain Perriot, et al.
Revue Medicale Suisse|January 22, 2020
[Neurology 2019]Matthieu Perrenoud, Vasiliki Pantazou, Patrik Michel, et al.
Revue Medicale Suisse|January 22, 2026
[Neurology : what's new in 2025]Andria Tziakouri, Valentin Loser, Alex Vicino, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
CNS Drugs|January 11, 2019
Intravenous Corticosteroids as an Adjunctive Treatment for Refractory and Super-Refractory Status Epilepticus: An Observational Cohort StudyVasiliki Pantazou, Jan Novy, Andrea O Rossetti
Presse Medicale (Paris, France : 1983)|March 7, 2015
Environmental factors in multiple sclerosisVasiliki Pantazou, Myriam Schluep, Renaud Du Pasquier
Life (Basel, Switzerland)|April 3, 2021
Interaction between Neurons and the Oligodendroglial Lineage in Multiple Sclerosis and Its Preclinical ModelsVasiliki Pantazou, Thomas Roux, Vanessa Oliveira Moreira, et al.
BMC Infectious Diseases|October 15, 2020
Vaccine-associated measles in a patient treated with natalizumab: a case reportAlix Miauton, Rainer Tan, Vasiliki Pantazou, et al.
Multiple Sclerosis and Related Disorders|April 10, 2021
Recurrence of disease activity after fingolimod discontinuation in older patients previously stable on treatmentVasiliki Pantazou, Caroline Pot, Renaud Du Pasquier, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 22, 2020
ANCA-associated life-threatening systemic vasculitis after alemtuzumab treatment for multiple sclerosisAlice Horisberger, Vasiliki Pantazou, Géraldine Cuendet, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|June 24, 2021
Discussing Challenges in Diagnosis of Tuberculous Meningitis and NeurosarcoidosisAlba Santos, Florian Desgranges, Marina Jovanovic, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 30, 2023
Ocrelizumab Impairs the Phenotype and Function of Memory CD8<sup>+</sup> T Cells: A 1-Year Longitudinal Study in Patients With Multiple SclerosisAmandine Mathias, Vasiliki Pantazou, Sylvain Perriot, et al.
Revue Medicale Suisse|January 22, 2020
[Neurology 2019]Matthieu Perrenoud, Vasiliki Pantazou, Patrik Michel, et al.
Revue Medicale Suisse|January 22, 2026
[Neurology : what's new in 2025]Andria Tziakouri, Valentin Loser, Alex Vicino, et al.
Pageof 1